Angiogenic molecular signature in colorectal cancer: Pharmacogenomic implications for the use of antiangiogenic therapies
In the framework of personalized medicine in antiangiogenesis, we took a translational research approach to explore the angiogenic molecular signature of advanced CRC patients. As derived from our findings in vitro, the tumour microenvironment of CRC metastases would be different to that of primar...
Main Authors: | Abajo, A. (Ana), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Servicio de Publicaciones de la Universidad de Navarra
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/36697 |
Similar Items
-
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array
by: Abajo, A. (Ana), et al.
Published: (2014) -
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients
by: Abajo, A. (Ana), et al.
Published: (2014) -
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
by: Abajo, A. (Ana), et al.
Published: (2014) -
Use of colonoscopy as a primary screening test for colorectal cancer in average risk people
by: Betes, M.T. (María Teresa), et al.
Published: (2012) -
Angiogénesis y endometriosis
by: Garcia-Manero, M. (Manuel), et al.
Published: (2014)